Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03116685 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
A Phase 3 study, sponsored by OxThera.
- Completed
- Registry status
- Phase 3
- Development phase
- 25
- Enrollment target
NCT03116685 is a Phase 3 study that has completed, run by OxThera. The registered enrollment target is 25 participants.
The verdict
NCT03116685, a Phase 3 study, has completed, sponsored by OxThera.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of OC5 in patients with PH.
Interventions
- OTHER Placebo
- BIOLOGICAL Oxabact OC5 - Oxalobacter formigenes HC-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2021-04-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03116685
The ClinicalTrials.gov registry entry for NCT03116685 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OxThera, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03116685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03116685 about?
NCT03116685 is a clinical study titled "A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria". This study will evaluate the efficacy and safety of OC5 in patients with PH.
What is the current status of trial NCT03116685?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2018-01-09. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT03116685?
The interventions under investigation include: Placebo (OTHER), Oxabact OC5 - Oxalobacter formigenes HC-1 (BIOLOGICAL).
Who is sponsoring clinical trial NCT03116685?
This trial is sponsored by OxThera, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.